Clinical Trials Browser

Has results × dostarlimab × Head & Neck × Clear all

NCT04313504 2026-05-07

Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC

Phase 2 Completed

10 enrolled 9 charts

Head and Neck Neoplasms